Debt / equity moved 11653 bp lower
Debt / equity changed -11653 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
179.74%→63.21%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HON financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash-flow margin moved 2925 bp lower
Operating cash-flow margin changed -2925 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
31.59%→2.34%2 prior comparisons
Operating cash flow / net income decreased 90.2%
Operating cash flow / net income changed -90.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.8→0.182 prior comparisons
Free-cash-flow margin moved 2227 bp lower
Free-cash-flow margin changed -2227 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
28.00%→5.73%2 prior comparisons
Debt / revenue moved 610 bp lower
Debt / revenue changed -610 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
289.82%→283.72%2 prior comparisons
Receivables / revenue moved 1611 bp higher
Receivables / revenue changed +1611 basis points from the comparable as-filed period.
85.73%→101.84%2 prior comparisons
Stock-based compensation decreased 188.9%
Stock-based compensation changed -188.9% from the comparable as-filed period.
-$36.0M→-$104.0M2 prior comparisons
Selling, general & administrative decreased 19.8%
Selling, general & administrative changed -19.8% from the comparable as-filed period.
$1.3B→$1.0B2 prior comparisons
Cash / debt moved 268 bp lower
Cash / debt changed -268 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
42.87%→40.19%4 prior comparisons
Capital expenditure changed across a sign change
Capital expenditure changed -145.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$374.0M→-$169.0M2 prior comparisons
SBC / revenue moved 174 bp lower
SBC / revenue changed -174 basis points from the comparable as-filed period.
-0.35%→-2.08%2 prior comparisons
R&D / revenue moved 1 bp higher
R&D / revenue changed +1 basis points from the comparable as-filed period.
4.78%→4.79%2 prior comparisons
Debt / equity moved 1791 bp lower
Debt / equity changed -1791 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
187.89%→169.98%2 prior comparisons
Operating cash flow / net income decreased 73.3%
Operating cash flow / net income changed -73.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.84→0.222 prior comparisons
Gross margin moved 128 bp lower
Gross margin changed -128 basis points from the comparable as-filed period.
38.86%→37.59%2 prior comparisons
Debt / revenue moved 3208 bp higher
Debt / revenue changed +3208 basis points from the comparable as-filed period.
292.13%→324.21%2 prior comparisons
Operating margin moved 19 bp higher
Operating margin changed +19 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
22.86%→23.05%2 prior comparisons
Revenue decreased 6.1%
Revenue changed -6.1% from the comparable as-filed period.
$10.4B→$9.7B2 prior comparisons
Operating income decreased 5.3%
Operating income changed -5.3% from the comparable as-filed period.
$2.4B→$2.2B2 prior comparisons
Inventory / revenue moved 188 bp lower
Inventory / revenue changed -188 basis points from the comparable as-filed period.
67.75%→65.86%2 prior comparisons
Net debt increased 14.4%
Net debt changed +14.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$19.9B→$22.8B4 prior comparisons
Debt / assets moved 218 bp higher
Debt / assets changed +218 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
38.56%→40.74%4 prior comparisons
Stockholders' equity increased 15.2%
Stockholders' equity changed +15.2% from the comparable as-filed period.
$16.1B→$18.5B2 prior comparisons
Current liabilities increased 7.3%
Current liabilities changed +7.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$21.6B→$23.2B4 prior comparisons
Free-cash-flow proxy decreased 5.4%
Free-cash-flow proxy changed -5.4% from the comparable as-filed period.
$1.0B→$961.0M3 prior comparisons
Capex / revenue moved 31 bp higher
Capex / revenue changed +31 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.93%→3.24%2 prior comparisons
Gross debt increased 4.2%
Gross debt changed +4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$30.2B→$31.5B4 prior comparisons
Reported total debt increased 4.2%
Reported total debt changed +4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$30.2B→$31.5B4 prior comparisons
Operating cash flow decreased 3.3%
Operating cash flow changed -3.3% from the comparable as-filed period.
$1.3B→$1.3B3 prior comparisons
Current ratio decreased 6.4%
Current ratio changed -6.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
1.29→1.214 prior comparisons
Total assets decreased 1.4%
Total assets changed -1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$78.4B→$77.3B4 prior comparisons
Research & development increased 8.9%
Research & development changed +8.9% from the comparable as-filed period.
$481.0M→$524.0M2 prior comparisons
Capital expenditure increased 4.0%
Capital expenditure changed +4.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$303.0M→$315.0M3 prior comparisons
Cost of revenue decreased 4.2%
Cost of revenue changed -4.2% from the comparable as-filed period.
$6.3B→$6.1B2 prior comparisons
R&D / revenue moved 75 bp higher
R&D / revenue changed +75 basis points from the comparable as-filed period.
4.65%→5.39%2 prior comparisons
Stock-based compensation increased 10.5%
Stock-based compensation changed +10.5% from the comparable as-filed period.
-$57.0M→-$51.0M2 prior comparisons
Receivables / revenue moved 55 bp higher
Receivables / revenue changed +55 basis points from the comparable as-filed period.
85.23%→85.78%2 prior comparisons
Current assets increased 0.4%
Current assets changed +0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$28.0B→$28.1B4 prior comparisons
SBC / revenue moved 3 bp higher
SBC / revenue changed +3 basis points from the comparable as-filed period.
-0.55%→-0.52%2 prior comparisons
Operating cash-flow margin moved 39 bp higher
Operating cash-flow margin changed +39 basis points from the comparable as-filed period.
12.74%→13.13%2 prior comparisons
Selling, general & administrative decreased 5.9%
Selling, general & administrative changed -5.9% from the comparable as-filed period.
$1.4B→$1.3B2 prior comparisons
Free-cash-flow margin moved 7 bp higher
Free-cash-flow margin changed +7 basis points from the comparable as-filed period.
9.81%→9.89%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.